|
Volumn 97, Issue 2, 2006, Pages 413-414
|
A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity [1]
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BOTULINUM TOXIN A;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
MUSCLE RELAXANT AGENT;
BLADDER EMPTYING;
CYSTOSCOPY;
DETRUSOR DYSSYNERGIA;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
IDIOPATHIC DETRUSOR OVERACTIVITY;
LETTER;
PATIENT;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RISK ASSESSMENT;
STATISTICAL SIGNIFICANCE;
SYMPTOM;
URINARY URGENCY;
URINE CATHETER;
URODYNAMICS;
FEMALE;
NEUROGENIC BLADDER;
NOTE;
TREATMENT OUTCOME;
URINE INCONTINENCE;
BOTULINUM TOXIN TYPE A;
FEMALE;
HUMANS;
NEUROMUSCULAR AGENTS;
TREATMENT OUTCOME;
URINARY BLADDER, NEUROGENIC;
URINARY INCONTINENCE;
|
EID: 33644854530
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/j.1464-410X.2006.06081_1.x Document Type: Letter |
Times cited : (9)
|
References (6)
|